Boston Scientific Q2 Adjusted EPS $0.53 Beats $0.49 Estimate, Sales $3.60B Beat $3.50B Estimate
Portfolio Pulse from Benzinga Newsdesk
Boston Scientific reported Q2 earnings of $0.53 per share, beating the analyst consensus estimate of $0.49 by 8.16%. This is a 20.45% increase over earnings of $0.44 per share from the same period last year. The company also reported quarterly sales of $3.60 billion, beating the analyst consensus estimate of $3.50 billion by 2.83%. This is a 10.94% increase over sales of $3.24 billion the same period last year.
July 27, 2023 | 10:36 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Boston Scientific's Q2 earnings and sales beat estimates, showing a significant YoY increase. This positive financial performance could potentially boost investor confidence and positively impact the stock price in the short term.
Boston Scientific's Q2 earnings and sales exceeded analyst estimates, indicating strong financial performance. This could potentially boost investor confidence and lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100